[Studies on the bioavailability of beta-aescin following oral administration of various dosage forms. Commentary on the work of Kunz et al. as well as Schrader et al., published in this journal].

Dittgen, M; Zimmermann, H; Wober, W; Höflich, C; Breitbarth, H; Timpe, C

[Studies on the bioavailability of beta-aescin following oral administration of various dosage forms. Commentary on the work of Kunz et al. as well as Schrader et al., published in this journal]. / Untersuchung der Bioverfügbarkeit von beta-Aescin nach oraler Verabreichung verschiedener Darreichungsformen. Kommentar zu den Ergebnissen von Kunz et al. sowie Schrader et al., publiziert in dieser Zeitschrift.

Dittgen, M; Zimmermann, H; Wober, W; Höflich, C; Breitbarth, H; Timpe, C.

Affiliation

Dittgen M; Jenapharm GmbH, Bereich Forschung und Entwicklung Jena, Germany.

Pharmazie ; 51(8): 608-10, 1996 Aug.

Article in De | MEDLINE | ID: mdl-8975254

Subject(s)

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Escin Type of study: Clinical_trials Limits: Adolescent / Adult / Humans / Male Language: De Journal: Pharmazie Journal subject: FARMACIA Year: 1996 Document type: Article Affiliation country: Alemania

Search on Google

Add to My VHL

XML

PubMed Links